Compare BIO-TECHNE Corp (TECH) vs ProShares Ultra Semiconductors (USD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BIO-TECHNE Corp vs ProShares Ultra Semiconductors — how do they compare? BIO-TECHNE Corp trades at $72.46 (market cap $11.36B), while ProShares Ultra Semiconductors trades at $94.84 (market cap $2.94B). The key difference: BIO-TECHNE Corp is far larger — about 3.9× ProShares Ultra Semiconductors's market cap, and BIO-TECHNE Corp pays a 0.44% dividend while ProShares Ultra Semiconductors pays none. Which is the better fit depends on your goals — on Pluang, investors hold BIO-TECHNE Corp for 64 Days and ProShares Ultra Semiconductors for 29 Days on average.
| TECH | USD | |
|---|---|---|
Market Cap | $11.36B | $2.94B |
Volume | 5,390,331 | 630,148 |
Sector | Health | Leveraged / Inverse |
52-Week High | $72.61 | $113.53 |
52-Week Low | $43.31 | $43.19 |
Typical Hold Time | 64 Days | 29 Days |
Enterprise Value | $11.39B | — |
Dividend Yield | 0.44% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TECH trades at $72.45, near its 52-week high of $72.70 (Defense World, 2026-09-28), with a slight 0.11% decline over 24 hours. The stock shows a bullish technical signal, supported by moving averages, while fundamentals reveal a high P/E of 62.46 and net income margin of 14.97% for 2025. Recent news highlights shareholder approval of its acquisition by Merck KGaA at $73.00 per share (PRNewsWire, 2026-09-23), a key catalyst for near-term price action.
The outlook is mixed: the acquisition offers upside to the current price, but elevated valuation ratios pose risks if earnings growth falters. Analyst consensus is divided with 46% buy ratings, and net income volatility from 2022-2025 signals execution challenges. Investors should weigh the acquisition premium against fundamental sustainability in a competitive life sciences tools sector.
USD stock is trading at $96.03, down 6.56% over the past 24 hours, with technical indicators showing a bullish overall signal despite recent weakness. The stock maintains strong moving average support with 9 buy signals versus 4 sell signals, while oscillators remain neutral. Recent corporate actions include a $0.13 dividend scheduled for September 2026. Support levels are established at $93 and $91, with resistance at $100 and $104.
The stock's technical foundation remains solid with bullish moving averages, though recent price action suggests near-term consolidation. Key resistance at $100 represents the next significant test, while support at $93 provides downside protection. The neutral oscillator readings indicate balanced momentum, requiring fundamental catalysts for sustained upward movement beyond current ranges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →About ProShares Ultra Semiconductors
USD is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Dow Jones U.S. Semiconductors™ Index. It is a tactical instrument designed for sophisticated traders looking to magnify short-term bullish views on the U.S. semiconductor industry, specifically focusing on large-cap leaders in the chip and equipment space.
Read more on USD →
